New research reveals that people who stop using popular weight-loss injections like Wegovy and Mounjaro may regain shed pounds much more quickly than those who end conventional lifestyle plans.
Published data in a leading medical journal demonstrates that while obese people frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications must be cognizant of the risk of quick weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery implies a return to starting mass in about a year and a half.
Analyzing Treatments
The research, which looked at dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with conventional dieting.
Scientists point out that individuals who shed pounds through lifestyle changes alone usually see a slower creep back—around 0.1 kg a month—after stopping.
The Reason for the Fast Rebound
Experts suggest the way of the jabs is key to understanding the amplified weight return.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating a significant risk."
A Chronic Issue?
Health authorities advise the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the significant potential of weight regain, the treatment should be considered ongoing.
This opinion is echoed by drug manufacturers, who say that the findings "underscore the chronic nature of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
People who have stopped the jabs explain a intense resurgence of hunger.
"It was like something that goes on and I was suddenly ravenous," said an individual.
The struggle is compounded if patients have not adopted permanent lifestyle or habit modifications during treatment.
Growing Interest
Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.
- Adoption is more common among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
Ultimately, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss relies on integrated behavioural management.
